You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 8,597,681

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,597,681 protect, and when does it expire?

Patent 8,597,681 protects XARTEMIS XR and is included in one NDA.

This patent has fifteen patent family members in eleven countries.

Summary for Patent: 8,597,681

Title:	Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
Abstract:	Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.
Inventor(s):	Park; Jae Han (Olivette, MO), Eisenhauer; Tiffani (Columbia, IL), Dhanarajan; Anish (Metuchen, NJ), Gupta; Vishal K. (Hillsborough, NJ), Overholt; Stephen (Middlesex, NJ)
Assignee:	Mallinckrodt LLC (Hazelwood, MO)
Application Number:	13/166,770
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,597,681
Patent Claim Types: see list of patent claims	Composition; Compound; Process; Formulation; Dosage form;

Drugs Protected by US Patent 8,597,681

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Mallinckrodt Inc	XARTEMIS XR	acetaminophen; oxycodone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	204031-001	Mar 11, 2014		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,597,681

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2011345329	⤷ Try a Trial
Brazil	112013015622	⤷ Try a Trial
Canada	2822553	⤷ Try a Trial
China	103402499	⤷ Try a Trial
European Patent Office	2654727	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.